Organism name | Mandragora autumnalis |
---|---|
Genus | Mandragora |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Mandragora autumnalis |
---|---|
Linked NCBI taxonomy ID | 389206 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P03372 | Estrogen receptor | NR3A1 | C00000619 C00000620 C00001221 C00001224 C00001233 C00002277 C00002293 C00029961 C00035535 C00035692 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00000619 C00001224 C00001228 C00001232 C00001233 C00002277 C00002293 C00002499 C00002503 C00002724 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000619 C00001221 C00001224 C00002476 C00002499 C00002503 C00002724 C00035535 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000619 C00000620 C00001224 C00002277 C00002292 C00002293 C00002499 C00002724 | 0 / 1 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000619 C00000620 C00001233 C00002277 C00002293 C00002724 C00035639 C00035692 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000619 C00000620 C00002277 C00002293 C00002476 C00002499 C00002500 C00002503 | 1 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000619 C00000620 C00002277 C00002292 C00002293 C00002499 C00002724 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000619 C00000620 C00002277 C00002292 C00002293 C00002499 C00002724 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000619 C00000620 C00002277 C00002292 C00002293 C00002499 C00002724 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000620 C00002724 C00019221 C00035535 C00035639 C00035690 C00035692 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00001221 C00001224 C00001228 C00001232 C00001233 C00019221 C00035692 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000619 C00000620 C00002277 C00002293 C00002499 C00002500 C00002503 | 1 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001232 C00002277 C00002293 C00002499 C00002503 C00003755 C00019221 | 1 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001224 C00001232 C00001233 C00002277 C00002292 C00002293 C00019221 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000619 C00000620 C00002277 C00002293 C00002499 C00002503 C00002724 | 0 / 3 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001224 C00001228 C00001232 C00002277 C00002293 C00002499 C00002503 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000619 C00000620 C00002277 C00002292 C00002293 C00002499 C00002724 | 1 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000620 C00001221 C00001228 C00001232 C00002503 C00019221 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001224 C00001232 C00002476 C00002499 C00002503 C00002724 | 3 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000619 C00000620 C00001232 C00002277 C00002293 C00002724 | 2 / 2 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002277 C00002293 C00002476 C00002499 C00002503 C00002724 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000619 C00000620 C00002277 C00002293 C00002499 C00002503 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000620 C00002277 C00002292 C00002293 C00002499 C00002724 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000619 C00000620 C00001176 C00002277 C00002293 C00002724 | 0 / 1 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000619 C00000620 C00001232 C00002277 C00002293 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002476 C00002499 C00002503 C00002724 C00029961 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000619 C00001221 C00001228 C00002499 C00002503 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001224 C00001228 C00002503 C00002724 C00019221 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001176 C00001221 C00001224 C00001232 C00002476 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 1 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000619 C00000620 C00002277 C00002293 C00019221 | 1 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000619 C00000620 C00001224 C00002277 C00002293 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002277 C00002292 C00002293 C00002450 C00035692 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 2 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000619 C00000620 C00001176 C00002277 C00002293 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000619 C00001221 C00001224 C00001233 C00035692 | 3 / 4 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000619 C00001221 C00001228 C00002499 C00002503 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 1 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000619 C00000620 C00001221 C00002277 C00002293 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000619 C00000620 C00002277 C00002292 C00002293 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000619 C00000620 C00001232 C00002277 C00002293 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000619 C00000620 C00002277 C00002293 | 2 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000619 C00001221 C00002499 C00002503 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000619 C00000620 C00002277 C00002293 | 3 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000619 C00000620 C00002277 C00002293 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002476 C00002499 C00002500 C00002503 | 0 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00001224 C00002277 C00002292 C00002293 | 11 / 10 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000619 C00000620 C00002277 C00002293 | 5 / 9 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000619 C00000620 C00002277 C00002293 | 1 / 1 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000619 C00000620 C00002277 C00002293 | 2 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001221 C00001224 C00001232 C00035692 | 5 / 3 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000619 C00000620 C00002277 C00002293 | 1 / 8 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000619 C00000620 C00002277 C00002293 | 2 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001176 C00001221 C00001224 C00001232 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001224 C00001228 C00001232 C00001233 | 2 / 2 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002277 C00002293 C00002499 C00002503 | 2 / 5 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002476 C00002499 C00002500 C00002503 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001224 C00001228 C00001232 C00001233 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001224 C00002476 C00002499 C00002503 | 2 / 2 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000619 C00000620 C00002277 C00002293 | 1 / 1 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002283 C00002499 C00002503 C00035552 | 6 / 4 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000619 C00000620 C00002277 C00002293 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000619 C00000620 C00002277 C00002293 | 2 / 1 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000619 C00000620 C00002277 C00002293 | 1 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001221 C00001224 C00002292 C00002724 | 3 / 2 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002476 C00002499 C00002500 C00002503 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000619 C00000620 C00002277 C00002293 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000619 C00000620 C00002277 C00002293 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000619 C00000620 C00002277 C00002293 | 2 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001232 C00002277 C00002293 | 0 / 0 |
P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00001224 C00001232 C00001233 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00000619 C00001221 C00002724 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000619 C00002499 C00002503 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000619 C00002499 C00002724 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002476 C00002499 C00002500 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002277 C00002293 C00019221 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002277 C00002293 C00019221 | 1 / 4 |
Q00796 | Sorbitol dehydrogenase | Enzyme | C00002476 C00002499 C00002503 | 0 / 0 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001228 C00035639 C00035692 | 2 / 3 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001224 C00035535 C00035692 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001232 C00002277 C00002293 | 1 / 2 |
P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00001224 C00001232 C00001233 | 0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002277 C00002292 C00002293 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00002277 C00002292 C00002293 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000619 C00002499 C00002503 | 5 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001232 C00002476 C00002724 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001221 C00001224 C00035692 | 0 / 0 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 3 / 2 |
P56817 | Beta-secretase 1 | A1A | C00002450 C00002476 C00002503 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001221 C00035535 C00035692 | 3 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002499 C00002503 C00029961 | 1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001232 C00002724 C00019221 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000619 C00002499 C00002503 | 0 / 0 |
P13726 | Tissue factor | Membrane receptor | C00001224 C00001232 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002503 C00002724 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002499 C00002503 | 1 / 1 |
P35610 | Sterol O-acyltransferase 1 | Enzyme | C00001224 C00001232 | 0 / 0 |
Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00001232 C00001233 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00002499 C00029961 | 0 / 0 |
O60603 | Toll-like receptor 2 | Membrane receptor | C00001228 C00001233 | 1 / 1 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002277 C00002293 | 1 / 1 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00000619 C00002499 | 1 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002499 C00002503 | 1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00001221 C00001232 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00002476 C00002503 | 1 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 C00002499 | 7 / 3 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 C00001228 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002277 C00002293 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002499 C00002503 | 1 / 1 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002499 C00002503 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002499 C00002500 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001228 C00002503 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000619 C00002724 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002292 C00002499 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002277 C00002293 | 0 / 0 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00002476 C00002503 | 1 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00001233 C00002292 | 1 / 0 |
P55210 | Caspase-7 | C14 | C00002499 C00002503 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001232 C00001233 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002476 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001224 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001228 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002476 | 0 / 0 |
P40925 | Malate dehydrogenase, cytoplasmic | Enzyme | C00019221 | 0 / 0 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00001224 | 0 / 0 |
O14842 | Free fatty acid receptor 1 | Free fatty acid receptor | C00001224 | 0 / 0 |
O15552 | Free fatty acid receptor 2 | Free fatty acid receptor | C00001176 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001228 | 2 / 2 |
P30556 | Type-1 angiotensin II receptor | Angiotensin receptor | C00019221 | 1 / 1 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00001233 | 0 / 0 |
P55789 | FAD-linked sulfhydryl oxidase ALR | Enzyme | C00002499 | 1 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001232 | 4 / 3 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00029961 | 0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001232 | 1 / 4 |
P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Oxidoreductase | C00002503 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002499 | 0 / 0 |
P12104 | Fatty acid-binding protein, intestinal | Other cytosolic protein | C00001233 | 0 / 0 |
Q05193 | Dynamin-1 | Structural | C00001228 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002476 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002476 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00001232 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002476 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002724 | 1 / 2 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002724 | 3 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002476 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00002499 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002499 | 0 / 0 |
O14980 | Exportin-1 | Unclassified protein | C00002476 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00002724 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002499 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002724 | 3 / 3 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00000619 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001176 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000620 | 0 / 0 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00002724 | 1 / 1 |
P07148 | Fatty acid-binding protein, liver | Unclassified protein | C00001232 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00035692 | 7 / 37 |
P14679 | Tyrosinase | Oxidoreductase | C00002503 | 4 / 2 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00002724 | 0 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00001224 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001228 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000619
C00000620
C00001221
C00001232
C00001233 C00035639 |
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001221
C00002499
C00002724
C00029961
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000619
C00000620
C00001232
C00001233
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000619
C00002499
C00002724
C00029961
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000619
C00002499
C00002724
C00029961
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
C00001228
C00001232
C00001233
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000619
C00002499
C00002724
C00029961
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000619
C00000620
C00001221
C00001233
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000619
C00001176
C00001221
C00029961
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001232
C00001233
C00002277
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000619
C00001221
C00029961
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000619
C00002499
C00002503
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000619
C00000620
C00001232
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000619
C00002499
C00002503
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000619
C00001233
C00002503
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000619
C00000620
C00002503
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001232
C00002724
C00029961
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000619
C00000620
C00001233
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000619
C00000620
C00001233
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000619
C00000620
C00002724
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000619
C00000620
C00002499
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000619
C00019221
C00035614
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001221
C00001228
C00001233
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000619
C00001232
C00002724
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000619
C00019221
C00035614
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000619
C00000620
|
199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
C00001228
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00001232
C00002724
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002724
C00029961
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00000619
C00001233
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000619
C00002277
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001233
C00002503
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00000619
C00001232
|
3760 | KCNJ3, GIRK1, KGA, KIR3.1 | potassium inwardly-rectifying channel, subfamily J, member 3 |
C00002277
C00002292
|
2914 | GRM4, GPRC1D, MGLUR4, mGlu4 | glutamate receptor, metabotropic 4 |
C00002277
C00002292
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000619
C00002499
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000619
C00029961
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000619
C00000620
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000619
C00000620
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000619
C00000620
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000619
C00000620
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001232
C00003755
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00001232
C00001233
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000619
C00000620
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002277
C00002292
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002277
C00002292
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000619
C00000620
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000619
C00000620
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000619
C00000620
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000619
C00000620
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000619
C00000620
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000619
C00000620
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000619
C00000620
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000619
C00000620
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000619
C00000620
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000619
C00002724
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000619
C00000620
|
7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000619
C00000620
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000619
C00000620
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000619
C00000620
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002503
C00029961
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000619
C00000620
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000619
C00000620
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000619
C00000620
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000619
C00000620
|
43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00002277
C00002292
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00001232
C00001233
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000619
C00000620
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001232
C00001233
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000619
C00000620
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002724
C00035639
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00001232
C00001233
|
10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000619
C00000620
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000619
C00000620
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000619
C00000620
|
4927 | NUP88 | nucleoporin 88kDa |
C00000619
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000620
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00000620
|
5168 | ENPP2, ATX, ATX-X, AUTOTAXIN, LysoPLD, NPP2, PD-IALPHA, PDNP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 (EC:3.1.4.39) |
C00035535
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00035535
|
5530 | PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B | protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00035535
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002277
|
9021 | SOCS3, ATOD4, CIS3, Cish3, SOCS-3, SSI-3, SSI3 | suppressor of cytokine signaling 3 |
C00000620
|
9564 | BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas | breast cancer anti-estrogen resistance 1 |
C00002277
|
8900 | CCNA1 | cyclin A1 |
C00002277
|
896 | CCND3 | cyclin D3 |
C00002277
|
898 | CCNE1, CCNE | cyclin E1 |
C00002277
|
9134 | CCNE2, CYCE2 | cyclin E2 |
C00002277
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00002277
|
991 | CDC20, CDC20A, bA276H19.3, p55CDC | cell division cycle 20 |
C00002277
|
990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00002277
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00002277
|
1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00002277
|
1128 | CHRM1, HM1, M1, M1R | cholinergic receptor, muscarinic 1 |
C00002277
|
1129 | CHRM2, HM2 | cholinergic receptor, muscarinic 2 |
C00002277
|
1131 | CHRM3, EGBRS, HM3 | cholinergic receptor, muscarinic 3 |
C00002277
|
1132 | CHRM4, HM4, M4R | cholinergic receptor, muscarinic 4 |
C00002277
|
29126 | CD274, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 | CD274 molecule |
C00000620
|
10850 | CCL27, ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27 | chemokine (C-C motif) ligand 27 |
C00000620
|
1392 | CRH, CRF | corticotropin releasing hormone |
C00002277
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00002277
|
1856 | DVL2 | dishevelled segment polarity protein 2 |
C00002277
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00000620
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002277
|
7430 | EZR, CVIL, CVL, VIL2 | ezrin |
C00002277
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002277
|
2741 | GLRA1, HKPX1, STHE | glycine receptor, alpha 1 |
C00002277
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00002503
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002503
|
3815 | KIT, C-Kit, CD117, PBT, SCFR | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1) |
C00002277
|
4057 | LTF, GIG12, HLF2, LF | lactotransferrin |
C00002277
|
4173 | MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21 | minichromosome maintenance complex component 4 (EC:3.6.4.12) |
C00002277
|
4175 | MCM6, MCG40308, Mis5, P105MCM | minichromosome maintenance complex component 6 (EC:3.6.4.12) |
C00002277
|
4855 | NOTCH4, INT3, NOTCH3 | notch 4 |
C00002277
|
5111 | PCNA | proliferating cell nuclear antigen |
C00002277
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00002277
|
5829 | PXN | paxillin |
C00002277
|
5881 | RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
C00002277
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002277
|
6580 | SLC22A1, HOCT1, OCT1, oct1_cds | solute carrier family 22 (organic cation transporter), member 1 |
C00002277
|
6582 | SLC22A2, OCT2 | solute carrier family 22 (organic cation transporter), member 2 |
C00002277
|
6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00002277
|
6583 | SLC22A4, OCTN1 | solute carrier family 22 (organic cation/zwitterion transporter), member 4 |
C00002277
|
8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00002503
|
7204 | TRIO, ARHGEF23, tgat | trio Rho guanine nucleotide exchange factor (EC:2.7.11.1) |
C00002277
|
47 | ACLY, ACL, ATPCL, CLATP | ATP citrate lyase (EC:2.3.3.8) |
C00002724
|
358 | AQP1, AQP-CHIP, CHIP28, CO | aquaporin 1 |
C00002724
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00002724
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002724
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002724
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002724
|
4512 | COX1, COI, MTCO1, MT-CO1 | cytochrome c oxidase subunit I |
C00002724
|
114757 | CYGB, HGB, STAP | cytoglobin |
C00002724
|
1830 | DSG3, CDHF6, PVA | desmoglein 3 |
C00002724
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002724
|
2200 | FBN1, ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFS1, OCTD, SGS, SSKS, WMS, WMS2 | fibrillin 1 |
C00002724
|
2201 | FBN2, CCA, DA9 | fibrillin 2 |
C00002724
|
2246 | FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1 | fibroblast growth factor 1 (acidic) |
C00002724
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00002724
|
3036 | HAS1, HAS | hyaluronan synthase 1 (EC:2.4.1.212) |
C00002724
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00002724
|
3852 | KRT5, CK5, DDD, DDD1, EBS2, K5, KRT5A | keratin 5 |
C00002724
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00002724
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002724
|
8985 | PLOD3, LH3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) |
C00002724
|
1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
5886 | RAD23A, HHR23A, HR23A | RAD23 homolog A (S. cerevisiae) |
C00002724
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002724
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001221
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00002724
|
7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 |
C00002724
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00002724
|
7306 | TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN | tyrosinase-related protein 1 (EC:1.14.18.-) |
C00002724
|
23460 | ABCA6, EST155051 | ATP-binding cassette, sub-family A (ABC1), member 6 |
C00000619
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000619
|
55114 | ARHGAP17, MST066, MST110, MSTP038, MSTP066, MSTP110, NADRIN, PP367, PP4534, RICH1, RICH1B, WBP15 | Rho GTPase activating protein 17 |
C00000619
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00000619
|
567 | B2M | beta-2-microglobulin |
C00000619
|
9774 | BCLAF1, BTF, bK211L9.1 | BCL2-associated transcription factor 1 |
C00000619
|
654 | BMP6, VGR, VGR1 | bone morphogenetic protein 6 |
C00000619
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00000619
|
57102 | C12orf4 | chromosome 12 open reading frame 4 |
C00000619
|
10203 | CALCRL, CGRPR, CRLR | calcitonin receptor-like |
C00000619
|
6357 | CCL13, CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 | chemokine (C-C motif) ligand 13 |
C00000619
|
6363 | CCL19, CKb11, ELC, MIP-3b, MIP3B, SCYA19 | chemokine (C-C motif) ligand 19 |
C00000619
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00029961
|
6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00000619
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00000619
|
729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00000619
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00000619
|
1236 | CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1 | chemokine (C-C motif) receptor 7 |
C00000619
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00000619
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00000619
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00000619
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00000619
|
1514 | CTSL, CATL, CTSL1, MEP | cathepsin L (EC:3.4.22.15) |
C00000619
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00000619
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000619
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000619
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00000619
|
1736 | DKC1, CBF5, DKC, DKCX, NAP57, NOLA4, XAP101 | dyskeratosis congenita 1, dyskerin |
C00000619
|
9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00000619
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00029961
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00000619
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00000619
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00000619
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00000619
|
1876 | E2F6, E2F-6 | E2F transcription factor 6 |
C00000619
|
1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00000619
|
133418 | EMB | embigin |
C00000619
|
2162 | F13A1, F13A | coagulation factor XIII, A1 polypeptide (EC:2.3.2.13) |
C00000619
|
26268 | FBXO9, FBX9, NY-REN-57, VCIA1, dJ341E18.2 | F-box protein 9 |
C00000619
|
2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00000619
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00000619
|
644076 | GLYCAM1 | glycosylation dependent cell adhesion molecule 1 (pseudogene) |
C00000619
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000619
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000619
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000619
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000619
|
2994 | GYPB, CD235b, GPB, GPB.NY, GYPHe.NY, GpMiIII, HGpMiIII, HGpMiVI, HGpMiX, MNS, PAS-3, SS | glycophorin B (MNS blood group) |
C00000619
|
54497 | HEATR5B | HEAT repeat containing 5B |
C00000619
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00000619
|
3106 | HLA-B, AS, HLAB, SPDA1 | major histocompatibility complex, class I, B |
C00000619
|
220988 | HNRNPA3, 2610510D13Rik, D10S102, FBRNP, HNRPA3 | heterogeneous nuclear ribonucleoprotein A3 |
C00000619
|
3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00000619
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00000619
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000619
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00000619
|
3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00000619
|
26034 | IPCEF1, PIP3-E, RP3-402L9.2 | interaction protein for cytohesin exchange factors 1 |
C00000619
|
3655 | ITGA6, CD49f, ITGA6B, VLA-6 | integrin, alpha 6 |
C00000619
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000619
|
3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00000619
|
3759 | KCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3 | potassium inwardly-rectifying channel, subfamily J, member 2 |
C00000619
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00000619
|
28985 | MCTS1, MCT-1, MCT1 | malignant T cell amplified sequence 1 |
C00000619
|
51318 | MRPL35, L35mt, MRP-L35 | mitochondrial ribosomal protein L35 |
C00000619
|
58475 | MS4A7, 4SPAN2, CD20L4, CFFM4, MS4A8 | membrane-spanning 4-domains, subfamily A, member 7 |
C00000619
|
4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00000619
|
4602 | MYB, Cmyb, c-myb, c-myb_CDS, efg | v-myb avian myeloblastosis viral oncogene homolog |
C00000619
|
10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00000619
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000619
|
10626 | TRIM16, EBBP | tripartite motif containing 16 |
C00000620
|
10606 | PAICS, ADE2, ADE2H1, AIRC, PAIS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) |
C00000619
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000619
|
8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00000619
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000619
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000619
|
10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00000619
|
5733 | PTGER3, EP3, EP3-I, EP3-II, EP3-III, EP3-IV, EP3e, PGE2-R | prostaglandin E receptor 3 (subtype EP3) |
C00000619
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000619
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00000619
|
6157 | RPL27A, L27A | ribosomal protein L27a |
C00000619
|
50484 | RRM2B, MTDPS8A, MTDPS8B, P53R2 | ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) |
C00000619
|
6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00000619
|
6383 | SDC2, CD362, HSPG, HSPG1, SYND2 | syndecan 2 |
C00000619
|
55752 | SEPT11 | septin 11 |
C00000619
|
6504 | SLAMF1, CD150, CDw150, SLAM | signaling lymphocytic activation molecule family member 1 |
C00000619
|
117247 | SLC16A10, MCT10, PRO0813, TAT1 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
C00000619
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00000619
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000619
|
6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00000619
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000619
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000619
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000619
|
7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00000619
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000619
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000619
|
7358 | UGDH, GDH, UDP-GlcDH, UDPGDH, UGD | UDP-glucose 6-dehydrogenase (EC:1.1.1.22) |
C00000619
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00029961
|
7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00000619
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00000619
|
7709 | ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67 | zinc finger and BTB domain containing 17 |
C00000619
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00002292
|
1103 | CHAT, CHOACTASE, CMS1A, CMS1A2 | choline O-acetyltransferase (EC:2.3.1.6) |
C00002292
|
4012 | LNPEP, CAP, IRAP, P-LAP, PLAP | leucyl/cystinyl aminopeptidase (EC:3.4.11.3) |
C00002292
|
7508 | XPC, RAD4, XP3, XPCC | xeroderma pigmentosum, complementation group C |
C00002499
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00029961
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001232
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00029961
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00001232
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00029961
|
335 | APOA1 | apolipoprotein A-I |
C00001232
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001232
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001232
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00035639
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001232
|
778733 |
C00001232
|
||
100136658 |
C00001232
|
||
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00001232
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00001232
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00019221
|
6514 | SLC2A2, GLUT2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
C00001232
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00001232
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00001233
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001233
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001233
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00001233
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001233
|
3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) |
C00001233
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00001233
|
3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) |
C00001233
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001233
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001233
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001233
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00001233
|
4494 | MT1F, MT1 | metallothionein 1F |
C00001233
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00001233
|
4502 | MT2A, MT2 | metallothionein 2A |
C00001233
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001233
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00001233
|
29893 | PSMC3IP, GT198, HOP2, HUMGT198A, ODG3, TBPIP | PSMC3 interacting protein |
C00001233
|
23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
C00001233
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00001233
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00001176
|
2571 | GAD1, CPSQ1, GAD, SCP | glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15) |
C00001176
|
5447 | POR, CPR, CYPOR, P450R | P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
C00001176
|
5649 | RELN, LIS2, PRO1598, RL | reelin |
C00001176
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#246300 | Leprosy, susceptibility to, 3; lprs3 |
O60603
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
P55789
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#267430 | Renal tubular dysgenesis; rtd |
P30556
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00344 | Leprosy |
O60603
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
Q13315 (related) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H00575 | Renal tubular dysgenesis |
P30556
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00002450
C00002277 C00002724 C00000619 C00002292 |
D000647 | Amnesia |
C00002450
C00002277 C00002724 C00002292 |
D009336 | Necrosis |
C00035535
C00002277 C00002724 C00001176 |
D013276 | Stomach Ulcer |
C00002277
C00000619 C00001176 |
D009203 | Myocardial Infarction |
C00002277
C00002292 C00003755 |
D007249 | Inflammation |
C00002277
C00000619 C00001176 |
D003072 | Cognition Disorders |
C00002292
C00001232 C00001233 |
D008545 | Melanoma |
C00029961
C00002724 C00000619 |
D012640 | Seizures |
C00035535
C00002277 C00002292 |
D015431 | Weight Loss |
C00035535
C00002724 C00002292 |
D013375 | Substance Withdrawal Syndrome |
C00002277
C00002292 |
D009410 | Nerve Degeneration |
C00000619
C00002292 |
D006930 | Hyperalgesia |
C00000619
C00001176 |
D001259 | Ataxia |
C00035535
C00002292 |
D009361 | Neoplasm Invasiveness |
C00035535
C00000619 |
D014987 | Xerostomia |
C00002277
C00002292 |
D014839 | Vomiting |
C00002277
C00002292 |
D017449 | Dermatitis, Allergic Contact |
C00000620
C00000619 |
D013274 | Stomach Neoplasms |
C00035535
C00000619 |
D004195 | Disease Models, Animal |
C00002292
C00001176 |
D014786 | Vision Disorders |
C00002277
C00002292 |
D053201 | Urinary Bladder, Overactive |
C00002277
C00001176 |
D014202 | Tremor |
C00002277
C00002292 |
D013610 | Tachycardia |
C00002277
C00002292 |
D010146 | Pain |
C00000619
C00001176 |
D053608 | Stupor |
C00002277
C00002292 |
D003877 | Dermatitis, Contact |
C00019221
C00000619 |
D013226 | Status Epilepticus |
C00002277
C00002292 |
D012021 | Reflex, Abnormal |
C00002277
C00002292 |
D001919 | Bradycardia |
C00002277
C00002292 |
D001943 | Breast Neoplasms |
C00002277
C00000619 |
D011654 | Pulmonary Edema |
C00002277
C00001232 |
D002375 | Catalepsy |
C00002277
C00002292 |
D020250 | Postoperative Nausea and Vomiting |
C00002277
C00002292 |
D011183 | Postoperative Complications |
C00002277
C00002292 |
D009325 | Nausea |
C00002277
C00002292 |
D019970 | Cocaine-Related Disorders |
C00002277
C00002292 |
D003128 | COMA |
C00002277
C00002292 |
D055370 | Lung Injury |
C00002292
C00001232 |
D015878 | Mydriasis |
C00002277
C00002292 |
D003693 | Delirium |
C00002277
C00002292 |
D009127 | Muscle Rigidity |
C00002277
C00002292 |
D062787 | Drug Overdose |
C00002277
C00002292 |
D007859 | Learning Disorders |
C00002277
C00002292 |
D009069 | Movement Disorders |
C00002292
C00001176 |
D007035 | Hypothermia |
C00002277
C00002292 |
D006973 | Hypertension |
C00002277
C00002292 |
D006327 | Heart Block |
C00002277
C00002292 |
D006212 | Hallucinations |
C00002277
C00002292 |
D001072 | Apraxias |
C00002292
|
D005334 | Fever |
C00002277
|
D005483 | Flushing |
C00002277
|
D005767 | Gastrointestinal Diseases |
C00002277
|
D004830 | Epilepsy, Tonic-Clonic |
C00002277
|
D006261 | Headache |
C00002277
|
D006323 | Heart Arrest |
C00002277
|
D004827 | Epilepsy |
C00002277
|
D006342 | Heart Rupture, Post-Infarction |
C00002277
|
D006940 | Hyperemia |
C00002277
|
D006943 | Hyperglycemia |
C00002277
|
D004831 | Epilepsies, Myoclonic |
C00002277
|
D007008 | Hypokalemia |
C00002277
|
D007022 | Hypotension |
C00002277
|
D020820 | Dyskinesias |
C00002277
|
D004381 | Duodenal Ulcer |
C00002277
|
D007410 | Intestinal Diseases |
C00002277
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00002277
|
D008133 | Long QT Syndrome |
C00002277
|
D015877 | Miosis |
C00002277
|
D003967 | Diarrhea |
C00002277
|
D018908 | Muscle Weakness |
C00002277
|
D009135 | Muscular Diseases |
C00002277
|
D009140 | Musculoskeletal Diseases |
C00002277
|
D009157 | Myasthenia Gravis |
C00002277
|
D006259 | Craniocerebral Trauma |
C00002277
|
D003329 | Coronary Vasospasm |
C00002277
|
D017202 | Myocardial Ischemia |
C00002277
|
D009207 | Myoclonus |
C00002277
|
D009216 | Myopia |
C00002277
|
D002637 | Chest Pain |
C00002277
|
D009422 | Nervous System Diseases |
C00002277
|
D020258 | Neurotoxicity Syndromes |
C00002277
|
D062025 | Organophosphate Poisoning |
C00002277
|
D010243 | Paralysis |
C00002277
|
D010437 | Peptic Ulcer |
C00002277
|
D010554 | Personality Disorders |
C00002277
|
D011041 | Poisoning |
C00002277
|
D002561 | Cerebrovascular Disorders |
C00002277
|
D002385 | Cataplexy |
C00002277
|
D011297 | Prenatal Exposure Delayed Effects |
C00002277
|
D001982 | Bronchial Diseases |
C00002277
|
D054537 | Atrioventricular Block |
C00002277
|
D012120 | Respiration Disorders |
C00002277
|
D012131 | Respiratory Insufficiency |
C00002277
|
D054138 | Sinus Arrest, Cardiac |
C00002277
|
D001281 | Atrial Fibrillation |
C00002277
|
D001146 | Arrhythmia, Sinus |
C00002277
|
D001145 | Arrhythmias, Cardiac |
C00002277
|
D001049 | Apnea |
C00002277
|
D013575 | Syncope |
C00002277
|
D056988 | Anterior Wall Myocardial Infarction |
C00002277
|
D013611 | Tachycardia, Atrioventricular Nodal Reentry |
C00002277
|
D013616 | Tachycardia, Sinus |
C00002277
|
D013617 | Tachycardia, Supraventricular |
C00002277
|
D017180 | Tachycardia, Ventricular |
C00002277
|
D016171 | Torsades de Pointes |
C00002277
|
D000855 | Anorexia |
C00002277
|
D000787 | Angina Pectoris |
C00002277
|
D014555 | Urination Disorders |
C00002277
|
D014607 | Uveomeningoencephalitic Syndrome |
C00002277
|
D020421 | Vagus Nerve Diseases |
C00002277
|
D014693 | Ventricular Fibrillation |
C00002277
|
D020236 | Amnesia, Transient Global |
C00002277
|
D010190 | Pancreatic Neoplasms |
C00035535
|
D019636 | Neurodegenerative Diseases |
C00035535
|
D006937 | Hypercholesterolemia |
C00002724
|
D006951 | Hyperlipoproteinemias |
C00002724
|
D015228 | Hypertriglyceridemia |
C00002724
|
D052456 | Hypoalphalipoproteinemias |
C00002724
|
D003875 | Drug Eruptions |
C00000619
|
D006331 | Heart Diseases |
C00000619
|
D006461 | Hemolysis |
C00000619
|
D008113 | Liver Neoplasms |
C00035535
|
D006967 | Hypersensitivity |
C00000619
|
D009362 | Neoplasm Metastasis |
C00000619
|
D009374 | Neoplasms, Experimental |
C00000619
|
D009389 | Neovascularization, Pathologic |
C00000619
|
D006984 | Hypertrophy |
C00035535
|
D003643 | Death |
C00035535
|
D010149 | Pain, Postoperative |
C00000619
|
D010300 | Parkinson Disease |
C00000619
|
D011833 | Radiation Injuries, Experimental |
C00000619
|
D012481 | Salmonella Infections, Animal |
C00000619
|
D012878 | Skin Neoplasms |
C00000619
|
D013035 | Spasm |
C00000619
|
D013203 | Staphylococcal Infections |
C00000619
|
D014581 | Urticaria |
C00000619
|
D002583 | Uterine Cervical Neoplasms |
C00000619
|
D020324 | Amnesia, Anterograde |
C00002292
|
D000648 | Amnesia, Retrograde |
C00002292
|
D015875 | Anisocoria |
C00002292
|
D001037 | Aphasia |
C00002292
|
D007172 | Erectile Dysfunction |
C00002277
|
D001927 | Brain Diseases |
C00002292
|
D001930 | Brain Injuries |
C00002292
|
D002389 | Catatonia |
C00002292
|
D003384 | Coxsackievirus Infections |
C00029961
|
D003221 | Confusion |
C00002292
|
D003704 | Dementia |
C00002292
|
D010787 | Photosensitivity Disorders |
C00002450
|
D006970 | Disorders of Excessive Somnolence |
C00002292
|
D004244 | Dizziness |
C00002292
|
D015352 | Dry Eye Syndromes |
C00002292
|
D004401 | Dysarthria |
C00002292
|
D004409 | Dyskinesia, Drug-Induced |
C00002292
|
D004948 | Esotropia |
C00002292
|
D005402 | Fistula |
C00002292
|
D006948 | Hyperkinesis |
C00002292
|
D018476 | Hypokinesia |
C00002292
|
D007634 | Keratitis |
C00002292
|
D007638 | Keratoconjunctivitis Sicca |
C00002292
|
D008103 | Liver Cirrhosis |
C00002292
|
D004890 | Erythema |
C00035639
|
D008569 | Memory Disorders |
C00002292
|
D020326 | Migraine without Aura |
C00002292
|
D009041 | Motion Sickness |
C00002292
|
D012532 | Scabies |
C00019221
|
D009293 | Opioid-Related Disorders |
C00002292
|
D010259 | Paranoid Disorders |
C00002292
|
D020795 | Photophobia |
C00002292
|
D011595 | Psychomotor Agitation |
C00002292
|
D011596 | Psychomotor Disorders |
C00002292
|
D011605 | Psychoses, Substance-Induced |
C00002292
|
D011681 | Pupil Disorders |
C00002292
|
D012798 | Sialorrhea |
C00002292
|
D005879 | Tourette Syndrome |
C00002292
|
D014549 | Urinary Incontinence |
C00002292
|
D014985 | Xerophthalmia |
C00002292
|
D055371 | Acute Lung Injury |
C00001232
|
D000860 | Anoxia |
C00001232
|
D005234 | Fatty Liver |
C00001232
|
D006520 | Hepatitis, Animal |
C00001232
|
D007333 | Insulin Resistance |
C00001232
|
D012128 | Respiratory Distress Syndrome, Adult |
C00001232
|
D003092 | Colitis |
C00001176
|
D006869 | Hydronephrosis |
C00001176
|
D007681 | Kidney Papillary Necrosis |
C00001176
|
D011350 | Proctocolitis |
C00001176
|
D011704 | Pyelonephritis |
C00001176
|
D014456 | Ulcer |
C00001176
|